2030 年尿道結石管理設備市場預測：按產品、最終用戶和地區分類的全球分析

根據 Stratistics MRC 的數據，2023 年全球尿道結石管理設備市場規模為 16.8 億美元，預計在預測期內將以 6.9% 的複合年成長率成長，到 2030 年達到 26.9 億美元。

尿道結石是指泌尿器官系統中結石的形成。尿道結石管理設備是用於診斷、治療和管理尿道結石（包括腎結石和尿路結石）的專用工具和設備。這些設備在微創治療、減少患者不適、縮短復原時間和改善尿道結石患者的治療效果方面發揮著重要作用。

根據歐洲泌尿系統協會的數據，尿道結石的盛行率在 1% 至 20% 之間。腎結石在加拿大、瑞典和美國等已開發國家相當常見（超過10%）。

尿道結石盛行率上升

尿道結石盛行率的上升，以全球腎結石和尿道結石發生率的上升為標誌，是尿道結石治療設備市場的關鍵促進因素。生活型態改變、飲食習慣和水分不足等因素會導致尿道結石發生率增加。此類病例的快速增加需要有效的管理和治療，從而刺激了對尿路結石治療設備的需求。隨著結石盛行率的不斷增加，對碎石碾碎、輸尿管鏡和取石工具等先進設備的需求不斷增加，創新的解決方案正在推動市場發展。

治療費用高

與尿道結石治療相關的費用（包括外科手術、醫療設備和後續護理）可能很高。這些高昂的費用限制了獲得先進治療方法和醫療設備的機會，特別是對於無力負擔或保險範圍不足的患者而言。經濟負擔阻礙人們選擇先進的治療方法，影響其採用，並阻礙市場成長。

對微創治療的需求不斷成長

與傳統手術方法相比，微創治療有術後疼痛減輕、住院時間短、恢復時間短、併發症風險低等優點，越來越受到病患的青睞。這一趨勢導致對支持輸尿管鏡、雷射碾碎和衝擊波碾碎等微創技術的尿道結石治療設備的需求激增。此外，這些設備可以精確瞄準結石，同時最大限度地減少對周圍組織的創傷。因此，市場成長的需求日益增加。

感染的風險

使用輸尿管支架和碾碎等尿道結石結石治療設備進行侵入性手術會增加感染的可能性。器械消毒不充分、器械保留時間過長、重複干預等都可能導致尿道感染和全身性感染疾病。這些感染疾病會導致併發症、延長住院時間、需要額外治療並影響患者的健康結果。結果，阻礙了市場需求。

COVID-19 的影響

COVID-19 大流行造成了分銷管道的中斷以及對企業和金融市場的財務影響。停電迫使多家小型醫院和老年住宅暫時關閉。此外，門診預約被推遲，電話和虛擬諮詢的需求增加。麻醉和治療計劃、病床和醫務人員的缺乏導致治療嚴重延誤，對全球尿道結石管理設備市場產生了負面影響。

輸尿管鏡細分市場預計將成為預測期內最大的細分市場

輸尿管內視鏡檢查部分估計佔最大佔有率。輸尿管鏡由配備小型攝影機和光纖技術的軟性或半剛性儀器組成，使泌尿系統能夠可視化並接近輸尿管或腎臟內的結石。輸尿管內的精確導航可實現碾碎、取石和雷射碾碎等手術。此外，輸尿管鏡在微創介入中發揮關鍵作用，減少患者不適，縮短復原時間，有助於有效的結石管理，從而幫助治療尿道結石，正在形成前景。

在預測期內，醫院領域的複合年成長率最高。

預計醫院業務在預測期內將出現良好成長。該醫院是尿道結石例診斷、治療和管理的主要中心。這些設施利用各種尿道結石管理設備，包括碎石機、輸尿管鏡、結石取出設備、支架和診斷影像設備。該醫院為尿道結石患者提供全面的泌尿系統手術和住院和門診服務。此細分市場涵蓋各種醫院環境，從大型學術醫療中心到小型社區醫院，所有這些醫院都採用和利用尿道結石管理設備來追求有效的患者照護。

比最大的地區

由於尿道結石盛行率上升、醫療保健支出增加、技術進步和老年人口增加，亞太地區在估計期間佔據了最大的市場佔有率。此外，醫療基礎設施的改善、醫療設施的普及以及對尿道結石治療方案的認知提高，都刺激了這些設備的採用。亞太市場為尋求滿足該地區尿道結石患者不斷變化的需求的製造商和供應商提供了利潤豐厚的機會。

複合年成長率最高的地區：

由於對微創治療的偏好、強勁的研發活動和有利的報銷政策，預計北美在預測期內將出現盈利成長。該地區包括美國和加拿大，擁有強大的醫療基礎設施、高昂的醫療成本以及對泌尿系統創新的高度重視。此外，越來越重視以患者為中心的護理和技術進步，以及主要市場參與者的存在，使北美成為尖端尿道結石治療解決方案的領先中心。

免費客製化服務

訂閱此報告的客戶可以存取以下免費自訂選項之一：

• 公司簡介
  • 其他市場參與者的綜合分析（最多 3 家公司）
  • 主要企業SWOT分析（最多3家企業）
• 區域分割
  • 根據客戶興趣對主要國家的市場估計、預測和複合年成長率（註：基於可行性檢查）
• 競爭基準化分析
  • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

• 概述
• 相關利益者
• 調查範圍
• 調查方法
  • 資料探勘
  • 資料分析
  • 資料檢驗
  • 研究途徑
• 調查來源
  • 主要調查來源
  • 二次調查來源
  • 先決條件

第3章市場趨勢分析

• 促進因素
• 抑制因素
• 機會
• 威脅
• 產品分析
• 最終用戶分析
• 新興市場
• 新型冠狀病毒感染疾病（COVID-19）的影響

第4章波特五力分析

• 供應商的議價能力
• 買方議價能力
• 替代品的威脅
• 新進入者的威脅
• 競爭公司之間的敵對關係

第5章全球尿道結石治療設備市場：依產品

• 震波碎石機
  • 體內
    • 超音波
    • 雷射
    • 空氣壓力
  • 體外
• 輸尿管腎鏡
  • 死板的
  • 靈活的
  • 半剛性

第6章全球尿道結石疾病管理設備市場：依最終用戶分類

• 診所及門診治療中心
• 醫院
• 其他最終用戶

第7章全球尿道結石結石治療設備市場：按地區

• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 德國
  • 英國
  • 義大利
  • 法國
  • 西班牙
  • 其他歐洲國家
• 亞太地區
  • 日本
  • 中國
  • 印度
  • 澳洲
  • 紐西蘭
  • 韓國
  • 其他亞太地區
• 南美洲
  • 阿根廷
  • 巴西
  • 智利
  • 南美洲其他地區
• 中東和非洲
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 卡達
  • 南非
  • 其他中東和非洲

第8章 主要進展

• 合約、夥伴關係、協作和合資企業
• 收購和合併
• 新產品發布
• 業務擴展
• 其他關鍵策略

第9章 公司簡介

• Olympus
• Boston Scientific
• Karl Storz
• Siemens Medical Solutions
• Richard Wolf
• Cook Medical
• Dornier
• Elmed
• MTS Medical
• Direxgroup
• Cybersonics
• Allengers
• BD
• DirexGroup
• CONMED Corporation
• Potent Medical
• HealthTronics, Inc

According to Stratistics MRC, the Global Urolithiasis Management Devices Market is accounted for $1.68 billion in 2023 and is expected to reach $2.69 billion by 2030 growing at a CAGR of 6.9% during the forecast period. Urolithiasis refers to the development of stones in the urinary system. Urolithiasis Management Devices are specialized tools and equipment used in the diagnosis, treatment, and management of urinary stones, including kidney stones and stones within the urinary tract. These devices play a crucial role in minimally invasive treatments, reducing patient discomfort, shortening recovery times, and improving outcomes for individuals suffering from urolithiasis.

According to the European Association of Urology, the prevalence of urinary stones ranges from 1% up to 20%. Renal stones are substantially more common (>10%) in developed nations like Canada, Sweden, and the U.S.

Market Dynamics:

Driver:

Rising prevalence of urolithiasis

The escalating prevalence of urolithiasis, characterised by a rising incidence of kidney stones and urinary tract stones worldwide, serves as a significant driver in the Urolithiasis Management Devices Market. Lifestyle changes, dietary habits, and factors like inadequate hydration contribute to the increased occurrence of urolithiasis. This surge in cases necessitates effective management and treatment, fuelling the demand for urolithiasis management devices. As the prevalence continues to grow, there is a heightened need for advanced devices such as lithotripters, ureteroscopes, and stone retrieval tools, driving the market towards innovative solutions.

Restraint:

High treatment costs

The expenses associated with urolithiasis management, including surgical procedures, medical devices, and follow-up care, can be substantial. These high costs limit accessibility to advanced treatments and devices, particularly for patients with limited financial means or inadequate insurance coverage. The financial burden discourages some individuals from opting for advanced procedures, impacting their adoption and hindering market growth.

Opportunity:

Growing demand for minimally invasive procedures

Patients increasingly prefer minimally invasive treatments due to several advantages, including reduced post-operative pain, shorter hospital stays, quicker recovery times, and a lower risk of complications compared to traditional surgical methods. This trend has surged the demand for urolithiasis management devices that support minimally invasive techniques such as ureteroscopy, laser lithotripsy, and shockwave lithotripsy. Additionally, these devices enable precise targeting of stones while minimising trauma to surrounding tissues. Thus, there is an increasing demand for market growth.

Threat:

Risk of infection

Invasive procedures involving urolithiasis management devices, such as ureteral stents or lithotripsy tools, increase the susceptibility to infections. Improperly sterilised equipment, prolonged device placement, or repeated interventions may lead to urinary tract infections or systemic infections. These infections can cause complications, prolong hospital stays, and necessitate additional treatments, impacting patient health outcomes. As a result, it will hinder market demand.

Covid-19 Impact

The COVID-19 pandemic is causing disruptions in distribution channels and through its financial impact on firms and financial markets. Due to obstacles, various small hospitals and elderly housing units had to be temporarily closed. Additionally, there was a delay in the scheduling of appointments for outpatient clinics, which increased the demand for phone or virtual clinics. The absence of anaesthesia or procedural slots, in-hospital beds, and medical personnel resulted in a major treatment backlog, which had a negative impact on the worldwide urolithiasis management device market.

The ureterorenoscopes segment is expected to be the largest during the forecast period

The ureterorenoscopes segment is estimated to hold the largest share. Ureterorenoscopes consist of flexible or semi-rigid instruments equipped with miniature cameras and fibre-optic technology, allowing urologists to visualise and access stones in the ureter or kidney. They facilitate precise navigation through the urinary tract, enabling procedures like stone fragmentation, retrieval, or laser lithotripsy. Furthermore, ureterorenoscopes play a pivotal role in less invasive interventions, reducing patient discomfort, shortening recovery times, and contributing to effective stone management, thereby shaping the landscape of urolithiasis treatment.

The hospitals segment is expected to have the highest CAGR during the forecast period

The hospitals segment is anticipated to have lucrative growth during the forecast period. Hospitals serve as primary centres for the diagnosis, treatment, and management of urolithiasis cases. Within these facilities, various urolithiasis management devices are utilized, including lithotripters, ureteroscopes, stone retrieval tools, stents, and imaging modalities. Hospitals provide a comprehensive range of urological procedures and surgeries, offering both inpatient and outpatient services for urolithiasis patients. The segment encompasses diverse hospital settings, from large academic medical centres to smaller community hospitals, all contributing to the adoption and utilisation of urolithiasis management devices in the quest for effective patient care.

Region with largest share:

Asia Pacific commanded the largest market share during the extrapolated period due to the rising prevalence of urolithiasis, increasing healthcare expenditure, technological advancements, and a growing geriatric population. Moreover, improving healthcare infrastructure, greater accessibility to medical facilities, and expanding awareness about urolithiasis treatment options fuel the adoption of these devices. The Asia-Pacific market presents lucrative opportunities for manufacturers and providers aiming to cater to the evolving needs of urolithiasis patients in the region.

Region with highest CAGR:

North America is expected to witness profitable growth over the projection period due to preference for minimally invasive procedures, strong research and development activities, and favourable reimbursement policies. The region, encompassing the United States and Canada, boasts a robust healthcare infrastructure, high healthcare expenditures, and a significant focus on technological innovations in urology. Moreover, the presence of key market players, along with a growing emphasis on patient-centric care and technological advancements, positions North America as a leading hub for cutting-edge urolithiasis treatment solutions.

Key players in the market

Some of the key players in the Urolithiasis Management Devices Market include Olympus, Boston Scientific, Karl Storz, Siemens Medical Solutions, Richard Wolf, Cook Medical, Dornier, Elmed, MTS Medical, Direxgroup, Cybersonics, Allengers, BD, DirexGroup, CONMED Corporation, Potent Medical , and HealthTronics, Inc.

Key Developments:

In July 2022, Calyxo announced the successful closure of its Series C investment round, securing USD 32.7 million. Based in California, Calyxo has developed the CVAC Aspiration system, designed to eliminate kidney stones without the need for surgery, utilizing irrigation and aspiration methods.

In March 2022, The FDA recognized Applaud Medical's Acoustic Enhancer technology as a breakthrough product. It is designed to break down calcium-based urinary stones that are obstructing or pose a significant risk of future hindrance, provided they are between 6mm and 20 mm in diameter.

Products Covered:

• Shock Wave Lithotripters
• Ureterorenoscopes

End Users Covered:

• Clinics and Ambulatory Care Centers
• Hospitals
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 End User Analysis
• 3.8 Emerging Markets
• 3.9 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Urolithiasis Management Devices Market, By Product

• 5.1 Introduction
• 5.2 Shock Wave Lithotripters
  • 5.2.1 Intracorporeal
    • 5.2.1.1 Ultrasound
    • 5.2.1.2 Laser
    • 5.2.1.3 Pneumatic
  • 5.2.2 Extracorporea
• 5.3 Ureterorenoscopes
  • 5.3.1 Rigid
  • 5.3.2 Flexible
  • 5.3.3 Semi Rigid

6 Global Urolithiasis Management Devices Market, By End User

• 6.1 Introduction
• 6.2 Clinics and Ambulatory Care Centers
• 6.3 Hospitals
• 6.4 Other End Users

7 Global Urolithiasis Management Devices Market, By Geography

• 7.1 Introduction
• 7.2 North America
  • 7.2.1 US
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 UK
  • 7.3.3 Italy
  • 7.3.4 France
  • 7.3.5 Spain
  • 7.3.6 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 Japan
  • 7.4.2 China
  • 7.4.3 India
  • 7.4.4 Australia
  • 7.4.5 New Zealand
  • 7.4.6 South Korea
  • 7.4.7 Rest of Asia Pacific
• 7.5 South America
  • 7.5.1 Argentina
  • 7.5.2 Brazil
  • 7.5.3 Chile
  • 7.5.4 Rest of South America
• 7.6 Middle East & Africa
  • 7.6.1 Saudi Arabia
  • 7.6.2 UAE
  • 7.6.3 Qatar
  • 7.6.4 South Africa
  • 7.6.5 Rest of Middle East & Africa

8 Key Developments

• 8.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 8.2 Acquisitions & Mergers
• 8.3 New Product Launch
• 8.4 Expansions
• 8.5 Other Key Strategies

9 Company Profiling

• 9.1 Olympus
• 9.2 Boston Scientific
• 9.3 Karl Storz
• 9.4 Siemens Medical Solutions
• 9.5 Richard Wolf
• 9.6 Cook Medical
• 9.7 Dornier
• 9.8 Elmed
• 9.9 MTS Medical
• 9.10 Direxgroup
• 9.11 Cybersonics
• 9.12 Allengers
• 9.13 BD
• 9.14 DirexGroup
• 9.15 CONMED Corporation
• 9.16 Potent Medical
• 9.17 HealthTronics, Inc

List of Tables

• Table 1 Global Urolithiasis Management Devices Market Outlook, By Region (2021-2030) ($MN)
• Table 2 Global Urolithiasis Management Devices Market Outlook, By Product (2021-2030) ($MN)
• Table 3 Global Urolithiasis Management Devices Market Outlook, By Shock Wave Lithotripters (2021-2030) ($MN)
• Table 4 Global Urolithiasis Management Devices Market Outlook, By Intracorporeal (2021-2030) ($MN)
• Table 5 Global Urolithiasis Management Devices Market Outlook, By Extracorporea (2021-2030) ($MN)
• Table 6 Global Urolithiasis Management Devices Market Outlook, By Ureterorenoscopes (2021-2030) ($MN)
• Table 7 Global Urolithiasis Management Devices Market Outlook, By Rigid (2021-2030) ($MN)
• Table 8 Global Urolithiasis Management Devices Market Outlook, By Flexible (2021-2030) ($MN)
• Table 9 Global Urolithiasis Management Devices Market Outlook, By Semi Rigid (2021-2030) ($MN)
• Table 10 Global Urolithiasis Management Devices Market Outlook, By End User (2021-2030) ($MN)
• Table 11 Global Urolithiasis Management Devices Market Outlook, By Clinics and Ambulatory Care Centers (2021-2030) ($MN)
• Table 12 Global Urolithiasis Management Devices Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 13 Global Urolithiasis Management Devices Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 14 North America Urolithiasis Management Devices Market Outlook, By Country (2021-2030) ($MN)
• Table 15 North America Urolithiasis Management Devices Market Outlook, By Product (2021-2030) ($MN)
• Table 16 North America Urolithiasis Management Devices Market Outlook, By Shock Wave Lithotripters (2021-2030) ($MN)
• Table 17 North America Urolithiasis Management Devices Market Outlook, By Intracorporeal (2021-2030) ($MN)
• Table 18 North America Urolithiasis Management Devices Market Outlook, By Extracorporea (2021-2030) ($MN)
• Table 19 North America Urolithiasis Management Devices Market Outlook, By Ureterorenoscopes (2021-2030) ($MN)
• Table 20 North America Urolithiasis Management Devices Market Outlook, By Rigid (2021-2030) ($MN)
• Table 21 North America Urolithiasis Management Devices Market Outlook, By Flexible (2021-2030) ($MN)
• Table 22 North America Urolithiasis Management Devices Market Outlook, By Semi Rigid (2021-2030) ($MN)
• Table 23 North America Urolithiasis Management Devices Market Outlook, By End User (2021-2030) ($MN)
• Table 24 North America Urolithiasis Management Devices Market Outlook, By Clinics and Ambulatory Care Centers (2021-2030) ($MN)
• Table 25 North America Urolithiasis Management Devices Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 26 North America Urolithiasis Management Devices Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 27 Europe Urolithiasis Management Devices Market Outlook, By Country (2021-2030) ($MN)
• Table 28 Europe Urolithiasis Management Devices Market Outlook, By Product (2021-2030) ($MN)
• Table 29 Europe Urolithiasis Management Devices Market Outlook, By Shock Wave Lithotripters (2021-2030) ($MN)
• Table 30 Europe Urolithiasis Management Devices Market Outlook, By Intracorporeal (2021-2030) ($MN)
• Table 31 Europe Urolithiasis Management Devices Market Outlook, By Extracorporea (2021-2030) ($MN)
• Table 32 Europe Urolithiasis Management Devices Market Outlook, By Ureterorenoscopes (2021-2030) ($MN)
• Table 33 Europe Urolithiasis Management Devices Market Outlook, By Rigid (2021-2030) ($MN)
• Table 34 Europe Urolithiasis Management Devices Market Outlook, By Flexible (2021-2030) ($MN)
• Table 35 Europe Urolithiasis Management Devices Market Outlook, By Semi Rigid (2021-2030) ($MN)
• Table 36 Europe Urolithiasis Management Devices Market Outlook, By End User (2021-2030) ($MN)
• Table 37 Europe Urolithiasis Management Devices Market Outlook, By Clinics and Ambulatory Care Centers (2021-2030) ($MN)
• Table 38 Europe Urolithiasis Management Devices Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 39 Europe Urolithiasis Management Devices Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 40 Asia Pacific Urolithiasis Management Devices Market Outlook, By Country (2021-2030) ($MN)
• Table 41 Asia Pacific Urolithiasis Management Devices Market Outlook, By Product (2021-2030) ($MN)
• Table 42 Asia Pacific Urolithiasis Management Devices Market Outlook, By Shock Wave Lithotripters (2021-2030) ($MN)
• Table 43 Asia Pacific Urolithiasis Management Devices Market Outlook, By Intracorporeal (2021-2030) ($MN)
• Table 44 Asia Pacific Urolithiasis Management Devices Market Outlook, By Extracorporea (2021-2030) ($MN)
• Table 45 Asia Pacific Urolithiasis Management Devices Market Outlook, By Ureterorenoscopes (2021-2030) ($MN)
• Table 46 Asia Pacific Urolithiasis Management Devices Market Outlook, By Rigid (2021-2030) ($MN)
• Table 47 Asia Pacific Urolithiasis Management Devices Market Outlook, By Flexible (2021-2030) ($MN)
• Table 48 Asia Pacific Urolithiasis Management Devices Market Outlook, By Semi Rigid (2021-2030) ($MN)
• Table 49 Asia Pacific Urolithiasis Management Devices Market Outlook, By End User (2021-2030) ($MN)
• Table 50 Asia Pacific Urolithiasis Management Devices Market Outlook, By Clinics and Ambulatory Care Centers (2021-2030) ($MN)
• Table 51 Asia Pacific Urolithiasis Management Devices Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 52 Asia Pacific Urolithiasis Management Devices Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 53 South America Urolithiasis Management Devices Market Outlook, By Country (2021-2030) ($MN)
• Table 54 South America Urolithiasis Management Devices Market Outlook, By Product (2021-2030) ($MN)
• Table 55 South America Urolithiasis Management Devices Market Outlook, By Shock Wave Lithotripters (2021-2030) ($MN)
• Table 56 South America Urolithiasis Management Devices Market Outlook, By Intracorporeal (2021-2030) ($MN)
• Table 57 South America Urolithiasis Management Devices Market Outlook, By Extracorporea (2021-2030) ($MN)
• Table 58 South America Urolithiasis Management Devices Market Outlook, By Ureterorenoscopes (2021-2030) ($MN)
• Table 59 South America Urolithiasis Management Devices Market Outlook, By Rigid (2021-2030) ($MN)
• Table 60 South America Urolithiasis Management Devices Market Outlook, By Flexible (2021-2030) ($MN)
• Table 61 South America Urolithiasis Management Devices Market Outlook, By Semi Rigid (2021-2030) ($MN)
• Table 62 South America Urolithiasis Management Devices Market Outlook, By End User (2021-2030) ($MN)
• Table 63 South America Urolithiasis Management Devices Market Outlook, By Clinics and Ambulatory Care Centers (2021-2030) ($MN)
• Table 64 South America Urolithiasis Management Devices Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 65 South America Urolithiasis Management Devices Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 66 Middle East & Africa Urolithiasis Management Devices Market Outlook, By Country (2021-2030) ($MN)
• Table 67 Middle East & Africa Urolithiasis Management Devices Market Outlook, By Product (2021-2030) ($MN)
• Table 68 Middle East & Africa Urolithiasis Management Devices Market Outlook, By Shock Wave Lithotripters (2021-2030) ($MN)
• Table 69 Middle East & Africa Urolithiasis Management Devices Market Outlook, By Intracorporeal (2021-2030) ($MN)
• Table 70 Middle East & Africa Urolithiasis Management Devices Market Outlook, By Extracorporea (2021-2030) ($MN)
• Table 71 Middle East & Africa Urolithiasis Management Devices Market Outlook, By Ureterorenoscopes (2021-2030) ($MN)
• Table 72 Middle East & Africa Urolithiasis Management Devices Market Outlook, By Rigid (2021-2030) ($MN)
• Table 73 Middle East & Africa Urolithiasis Management Devices Market Outlook, By Flexible (2021-2030) ($MN)
• Table 74 Middle East & Africa Urolithiasis Management Devices Market Outlook, By Semi Rigid (2021-2030) ($MN)
• Table 75 Middle East & Africa Urolithiasis Management Devices Market Outlook, By End User (2021-2030) ($MN)
• Table 76 Middle East & Africa Urolithiasis Management Devices Market Outlook, By Clinics and Ambulatory Care Centers (2021-2030) ($MN)
• Table 77 Middle East & Africa Urolithiasis Management Devices Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 78 Middle East & Africa Urolithiasis Management Devices Market Outlook, By Other End Users (2021-2030) ($MN)